Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-ĸB)
- 15 January 2011
- journal article
- Published by Elsevier BV in Experimental and Molecular Pathology
- Vol. 90 (3), 244-251
- https://doi.org/10.1016/j.yexmp.2011.01.002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The interaction of angiocidin with tissue transglutaminaseExperimental and Molecular Pathology, 2010
- Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine productionNature Immunology, 2009
- Stromal MCP‐1 in mammary tumors induces tumor‐associated macrophage infiltration and contributes to tumor progressionInternational Journal of Cancer, 2009
- NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosisProceedings of the National Academy of Sciences, 2004
- Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin‐1Journal of Cellular Biochemistry, 2004
- Decorin suppresses tumor cell-mediated angiogenesisOncogene, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Structural Studies of the Interaction between Ubiquitin Family Proteins and Proteasome Subunit S5aBiochemistry, 2002
- Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cellsMolecular and Cellular Endocrinology, 1989
- Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cellsCancer, 1987